(Q51536940)

English

Diffuse Ventricular Fibrosis on Cardiac Magnetic Resonance Imaging Associates With Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy.

scientific article published on 3 February 2016

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/26840595

Diffuse Ventricular Fibrosis on Cardiac Magnetic Resonance Imaging Associates With Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy. (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/26840595

cardiac magnetic resonance imaging

1 reference

based on heuristic

inferred from title

ventricular tachycardia

1 reference

based on heuristic

inferred from title

Jonathan M Kalman

10

object named as

Jonathan M Kalman

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/26840595

author name string

Alex J A McLELLAN

1

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/26840595

Andris H Ellims

2

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/26840595

Sandeep Prabhu

3

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/26840595

Alex Voskoboinik

4

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/26840595

Leah M Iles

5

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/26840595

James L Hare

6

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/26840595

David M Kaye

7

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/26840595

Ivan Macciocca

8

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/26840595

Justin A Mariani

9

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/26840595

Andrew J Taylor

11

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/26840595

Peter M Kistler

12

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/26840595

publication date

3 February 2016

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/26840595

Journal of Cardiovascular Electrophysiology

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/26840595

27

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/26840595

5

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/26840595

571-580

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/26840595

2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

1 reference

https://api.crossref.org/works/10.1111%2FJCE.12948

21 January 2018

Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study

1 reference

https://api.crossref.org/works/10.1111%2FJCE.12948

21 January 2018

Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1111%2FJCE.12948

21 January 2018

Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings

1 reference

https://api.crossref.org/works/10.1111%2FJCE.12948

21 January 2018

Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1111%2FJCE.12948

21 January 2018

Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1111%2FJCE.12948

21 January 2018

Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1111%2FJCE.12948

21 January 2018

The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1111%2FJCE.12948

21 January 2018

Prognostic role of CMR in patients presenting with ventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1111%2FJCE.12948

21 January 2018

T1 Mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy.

1 reference

https://api.crossref.org/works/10.1111%2FJCE.12948

21 January 2018

Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction

1 reference

https://api.crossref.org/works/10.1111%2FJCE.12948

21 January 2018

T1 mapping of the gadolinium-enhanced myocardium: adjustment for factors affecting interpatient comparison

1 reference

https://api.crossref.org/works/10.1111%2FJCE.12948

21 January 2018

Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1111%2FJCE.12948

21 January 2018

Myocardial fibrosis evaluated by Look-Locker and late gadolinium enhancement magnetic resonance imaging in apical hypertrophic cardiomyopathy: association with ventricular tachyarrhythmia and risk factors

1 reference

https://api.crossref.org/works/10.1111%2FJCE.12948

21 January 2018

Diffuse ventricular fibrosis measured by T₁ mapping on cardiac MRI predicts success of catheter ablation for atrial fibrillation

1 reference

https://api.crossref.org/works/10.1111%2FJCE.12948

21 January 2018

Occurrence and Frequency of Arrhythmias in Hypertrophic Cardiomyopathy in Relation to Delayed Enhancement on Cardiovascular Magnetic Resonance

1 reference

https://api.crossref.org/works/10.1111%2FJCE.12948

21 January 2018

Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1111%2FJCE.12948

21 January 2018

Identifiers

10.1111/JCE.12948

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/26840595

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/26840595

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51536940&oldid=1577071428"